| DAA884 |
Widespread degeneration of glomerular blood vessels |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA730 |
White matter volume decreases |
Physiological |
white matter |
Human |
— |
— |
|
| DAA826 |
Weaker digestive tract muscle contractions |
Physiological |
alimentary system, smooth muscle |
Human |
— |
— |
|
| DAA826 |
Weaker digestive tract muscle contractions |
Physiological |
alimentary system, smooth muscle |
Human |
— |
— |
|
| DAA846 |
Weakening of intestinal wall |
Physiological |
large intestine |
Human |
— |
— |
|
| DAA436 |
WD repeat domain 12 |
Molecular |
skeletal muscle |
Human |
WDR12 |
3.0% Decrease Gene Expression Level |
|
| DAA250 |
WD repeat and SOCS box-containing 2 |
Molecular |
brain |
Human |
WSB2 |
5.0% Decrease Gene Expression Level |
|
| DAA703 |
Wall increases in thickness |
Physiological |
left ventricle |
Human |
— |
— |
|
| DAA2078 |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) increases with age |
Molecular |
ovary |
Human |
RELA |
60.0% Increase Gene Expression Level |
|
| DAA195 |
v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) |
Molecular |
brain |
Human |
RALB |
7.0% Decrease Gene Expression Level |
|
| DAA2070 |
von Willebrand factor A domain containing 5A decreases with age |
Molecular |
ovary |
Human |
VWA5A |
56.0% Decrease Gene Expression Level |
|
| DAA948 |
Volume of perivascular space around thymus increases |
Physiological |
thymus |
Human |
— |
— |
|
| DAA936 |
Volume of hematopoietic bone marrow decreases |
Physiological |
bone marrow |
Human |
— |
— |
|
| DAA247 |
voltage-dependent anion channel 1 |
Molecular |
brain |
Human |
VDAC1 |
10.0% Decrease Gene Expression Level |
|
| DAA777 |
Visual memory declines |
Psychological |
brain |
Human |
— |
— |
|
| DAA2583 |
Vision loss |
Physiological |
visual apparatus |
Human |
— |
— |
|
| DAA249 |
visinin-like 1 |
Molecular |
brain |
Human |
VSNL1 |
6.0% Decrease Gene Expression Level |
|
| DAA788 |
Viscoelastic modulus of brain tissue decreases |
Physiological |
brain |
Human |
— |
— |
|
| DAA588 |
Viral hepatitis |
Pathological |
liver |
Human |
— |
SeriesMorbidity |
|
| DAA248 |
vimentin |
Molecular |
brain |
Human |
VIM |
11.0% Increase Gene Expression Level |
|
| DAA565 |
vesicle transport through interaction with t-SNAREs homolog 1B (yeast) |
Molecular |
skeletal muscle |
Human |
VTI1B |
3.0% Decrease Gene Expression Level |
|
| DAA246 |
vesicle-associated membrane protein 3 (cellubrevin) |
Molecular |
brain |
Human |
VAMP3 |
7.0% Increase Gene Expression Level |
|
| DAA245 |
vesicle-associated membrane protein 2 (synaptobrevin 2) |
Molecular |
brain |
Human |
VAMP2 |
4.0% Decrease Gene Expression Level |
|
| DAA517 |
very low density lipoprotein receptor |
Molecular |
skeletal muscle |
Human |
VLDLR |
4.0% Decrease Gene Expression Level |
|
| DAA50 |
versican |
Molecular |
brain |
Human |
VCAN |
20.0% Increase Gene Expression Level |
|